Skip to content

Role of respiratory biofeedback in improving pulmonary function and quality of life in stable C.O.P.D. patients : a randomized Controlled trialRole of respiratory biofeedback in improving pulmonary function and quality of life in stable C.O.P.D. patients : a randomized controlled trial

Role of respiratory biofeedback in improving pulmonary function and quality of life in stable C.O.P.D. patients: A Randomized controlled trial

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/03/051095
Enrollment
70
Registered
2023-03-27
Start date
Unknown
Completion date
Unknown
Last updated
2023-04-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J449- Chronic obstructive pulmonary disease, unspecified

Interventions

Intervention1: incentive spirometer: all the enrolled patents will be randomized in two groups. group A will use Incentive spirometry and do conventional pulmonary exercise, and group B will do only C

Sponsors

Department of Physical Medicine and Rehabilitation
Lead Sponsor
Department of Physical Medicine and Rehabilitation
Collaborator

Eligibility

Inclusion criteria

Inclusion criteria: 1.Age 40 to 65 years both males and females. 2.Mild to severe stable COPD patients (GOLD Staging 1, 2 and 3). 3.Patients under the care of specialist receiving an accepted medical regimen for COPD for at least 6 weeks. 4.There is no history of psychiatric and neurological disorder. 5.Patients giving consent to participate in this study.

Exclusion criteria

Exclusion criteria: 1.Patients with very severe COPD (GOLD Staging 4) 2.History of previously known any other chronic lung disease. 3.Patients with co-existing cardiac disease like Congestive heart failure, ischemic heart disease etc. 4.Any bony deformities of spine like scoliosis and kyphosis 5.Patients not willing to participate in study

Design outcomes

Primary

MeasureTime frame
St. Georges Respiratory Questionnaire (SGRQ) FEV1, FVC, FEV1/FVC(%) Timepoint: at baseline and at 4 week

Secondary

MeasureTime frame
1) Lung Function (FEV1, FVC, FEV1/FVC) 2) Quality of Life (SGRQ questionnaire) FOLLOW UP 4 weeks after home based Incentive spirometry exercise training Timepoint: 4 weeks;1) Lung Function (FEV1, FVC, FEV1/FVC) 2) Quality of Life (SGRQ questionnaire) FOLLOW UP 4 weeks after home based Incentive spirometry exercise training Timepoint: 4 weeks

Countries

India

Contacts

Public ContactMohd rashid

King Georges Medical University Lucknow

sudhirpmr10@gmail.com08169802961

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026